大麻二酚市场：依来源类型、依产品类型、依应用、依通路、按地区

2025 年全球大麻二酚市场规模预估为 94.6 亿美元，预计到 2032 年将达到 275.7 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 16.5%。

数字。 2025 年大麻二酚各地区市场占有率（%）

大麻二酚（CBD）是大麻植物（例如汉麻和印度大麻）中发现的主要大麻素之一。大麻二酚具有多种潜在的医疗和治疗作用，但不具备四氢大麻酚（THC， Delta-9-四氢大麻酚）的精神活性作用。人们越来越意识到 CBD 对失眠、慢性疼痛、焦虑和癫痫等疾病的治疗作用，这可能会促进人们对含有大麻二酚的产品的采用。此外，大麻已在多个国家合法用于医疗用途，为大麻二酚製造商和销售商提供了新的机会。目前正在进行各种研究以检验CBD的功效和安全性，这可能会进一步扩大未来CBD产品的商业化前景。

市场动态

医用大麻的日益合法化和大麻产品的日益普及可能会推动全球大麻二酚市场的成长。公司增加对大麻研究和新产品发布的投资可以推动市场成长。此外，文明病、精神障碍和慢性病的盛行率不断上升，将推动对治疗性 CBD 产品的需求。然而，某些法规可能会阻碍市场成长。此外，缺乏功效和安全性的临床试验资料也阻碍了市场的成长。另一方面，其在食品饮料和个人保健产品中的日益普及可能为市场扩张提供机会。

研究的主要特点

本报告对全球大麻二酚市场进行了详细分析，并提供了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%），假设 2024 年为基准年。

它还强调了各个领域的潜在商机并解释了该市场的有吸引力的投资提案矩阵。

它还提供了对市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。

它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球大麻二酚市场的主要企业。

本研究涉及的主要企业包括 CV Sciences, Inc.、Isodiol、Medical Marijuana Inc.、Aurora Cannabis、ENDOCA、Elixinol 和 GAIA Botanicals LLC。

本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。

全球大麻二酚市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

透过分析全球大麻二酚市场所使用的各种策略矩阵，相关人员将能够更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• 一致的机会图 (COM)

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 影响分析
• 市场趋势
• 监管情景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

4. 全球大麻二酚市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 政府倡议
• COVID-19 市场影响

5. 2020-2032 年全球大麻二酚市场（按来源类型划分）（十亿美元）

• 介绍
• 麻
• 大麻

6. 2020-2032 年全球大麻二酚市场（按产品划分）（十亿美元）

• 介绍
• 油
• 酊剂
• 栓剂
• 经皮吸收贴片
• 电子烟油
• 分离株
• 乳霜和滚珠
• 胶囊
• 锭剂
• 其他的

7. 2020 年至 2032 年全球大麻二酚市场（按应用划分）（十亿美元）

• 介绍
• 医疗
• 慢性疼痛
• 精神障碍
• 癌症
• 其他的
• 个人使用
• 药品
• 健康
• 饮食
• 个人护理及化妆品
• 营养补充品
• 其他的

8. 2020-2032 年全球大麻二酚市场（按地区划分）（十亿美元）

• 介绍
• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东

Global Cannabidiol Market is estimated to be valued at USD 9.46 Bn in 2025 and is expected to reach USD 27.57 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.5% from 2025 to 2032.

Figure. Cannabidiol Market Share (%), By Region 2025

Cannabidiol or CBD is one of the primary cannabinoids found in cannabis plants like hemp and marijuana. It has several potential medical benefits and therapeutic effects without the psychotropic effects of THC, Delta-9-tetrahydrocannabinol. Rising awareness about the therapeutic properties of CBD for conditions like insomnia, chronic pain, anxiety, and epilepsy can boost adoption of cannabidiol-infused products. Moreover, legalization of cannabis in several countries for medical use offer new opportunities for cannabidiol manufacturers and vendors. Various studies examining the efficacy and safety of CBD are underway, which can further augment the commercialization scope of CBD products in the future.

Market Dynamics:

Rising legalization of medical cannabis and growing adoption of cannabis-based products can drive the global cannabidiol market growth. Increasing investments by companies in cannabis research and new product launches can drive the market growth. Furthermore, rising prevalence of lifestyle diseases, mental health disorders, and chronic conditions boosts demand for therapeutic CBD products. However, certain regulations can hamper the market growth. Lack of clinical trials data on efficacy and safety can also hamper the market growth. Meanwhile, growing adoption in food & beverages, and personal care products can offer opportunities for market expansion.

Key Features of the Study:

This report provides in-depth analysis of the global cannabidiol market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cannabidiol market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include CV Sciences, Inc., Isodiol, Medical Marijuana Inc., Aurora Cannabis, ENDOCA, Elixinol and GAIA Botanicals LLC

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global cannabidiol market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cannabidiol market

Detailed Segmentation-

• By Source Type
  • Hemp
  • Marijuana
• By Product
  • Oil
  • Tinctures
  • Suppository
  • Transdermal patches
  • Vape Oil
  • Isolates
  • Creams and Roll-on
  • Capsules
  • Tablet
  • Others
• By Application
  • Medical
  • Chronic Pain
  • Mental Disorders
  • Cancer
  • Others
  • Personal Use
  • Pharmaceuticals
  • Wellness
  • Food & Beverages
  • Personal Care & Cosmetics
  • Nutraceuticals
  • Others
• By Distribution Channel
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • ENDOCA
  • Cannoid LLC
  • Medical Marijuana Inc.
  • Folium Biosciences
  • Elixinol
  • NuLeaf Naturals LLC
  • Isodiol International Inc.
  • Pharmahemp d.o.o.
  • Aurora Cannabis Inc.
  • CV Sciences
  • Medterra CBD
  • Canopy Growth Corporation
  • Aphria, Inc.
  • GW Pharmaceuticals Plc
  • Organigram Holding Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Source Type
  • Market Snapshot, By Product
  • Market Snapshot, By Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Cannabidiol Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Cannabidiol Market, By Source Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hemp
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Marijuana
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cannabidiol Market, By Product, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oil
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tinctures
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Suppository
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Transdermal patches
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Vape Oil
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Isolates
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Creams and Roll-on
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Capsules
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tablet
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cannabidiol Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Medical
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Pain
• Mental Disorders
• Cancer
• Others
• Personal Use
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pharmaceuticals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Wellness
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Food & Beverages
• Personal Care & Cosmetics
• Nutraceuticals
• Others

8. Global Cannabidiol Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Source Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Company Profiles
  • ENDOCA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Cannoid LLC
  • Medical Marijuana Inc.
  • Folium Biosciences
  • Elixinol
  • NuLeaf Naturals LLC
  • Isodiol International Inc.
  • Pharmahemp d.o.o.
  • Aurora Cannabis Inc.
  • CV Sciences
  • Medterra CBD
  • Canopy Growth Corporation
  • Aphria, Inc.
  • GW Pharmaceuticals Plc
  • Organigram Holding Inc.

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact